China · Investor

Highlight Capital

Last cheque observed May 2026; 78 cheques on record.

Deploying nowNew fund $904K, Nov 2022VC firmWebsite unconfirmed

Series BVentureSeries AHealthcareTechnology

Deploying now
38%of best year11cheques in 12 months, 78 on record
Since the last cheque176days00hrs00min00sec
Median round$25MRounds led0 of 78Sole investor23 roundsMostly inUnited States, 36%
Pitch Highlight Capital

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. Tell us which if you know.

Highlight Capital highlights

  1. 01

    11 cheques in the last 12 months

  2. 02

    Mostly Series B and Venture: 54% of its rounds

  3. 03

    Sole investor in 23 rounds, median $14M

What they do

Type
VC firm
Cheque size
Not stated
Sectors
HealthcareTechnology
Based in
China
Cold pitches
Accepted

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first78 appearances

  1. 2026

    8 rounds

  2. May
    Vivatides TherapeuticsSeries A · Ventureburn$54MWith 3 others
  3. May
    NuclidiumSeries B · CH$34MWith 3 others
  4. Apr
    ImageneBioUS$30MWith 4 others
  5. Apr
    Allegria TherapeuticsGrant · CH$1.5MSole investor
  6. Feb
    Spirit AISeries A · CN · Ventureburn$250MWith 7 others
  7. Jan
    SpuriousSeed$35MSole investor
  8. Jan
    Yiteng MedicalSeries A$14MSole investor
  9. Jan
    Realm of IlluminationVentureUndisclosedWith 4 others
  10. 2025

    25 rounds

  11. Dec
    Shouxing TechnologyVenture · USUndisclosedWith 3 others
  12. Dec
    T-CURXSeries A · DE$20MWith 1 other
  13. Nov
    Novachip MicroelectronicsPre-seed$14MSole investor
  14. Oct
    AsiaSonic SemiconductorSeries B$14MSole investor
  15. Oct
    USUN BIOVentureUndisclosedSole investor
  16. Oct
    Ultra SocialSeries B · JP$7.6MWith 2 others
  17. Sept
    Yuansheng IntelligenceVentureUndisclosedSole investor
  18. Sept
    Sieran MedicalVenture$14MWith 1 other
  19. Sept
    E-nitiate BiopharmaceuticalsSeries B$28MSole investor
  20. Sept
    EnnovabioVentureUndisclosedWith 1 other
  21. Aug
    Base TherapeuticsVentureUndisclosedWith 2 others
  22. Aug
    XINGYUN GROUPVentureUndisclosedWith 5 others
  23. Aug
    MethuselahSeries B$15MWith 2 others
  24. Jul
    NuclidiumSeries B · CH · DTCF DeepTech & Climate Fonds$99MWith 11 others
  25. Jul
    Abiochem BiotechnologySeries D$63MWith 2 others
  26. Jul
    Qinghui LiannuoVentureUndisclosedSole investor
  27. Jul
    VelaVigoSeed$60MWith 5 others
  28. Jun
    Tianchen BiotechnologySeries C$28MWith 1 other
  29. Jun
    Shenandoah TherapeuticsSeed · US$20MWith 1 other
  30. Jun
    Arthrosi TherapeuticsSeries E · US$153MSole investor
  31. May
    NuevocorSeries B · SG$45MWith 3 others
  32. May
    LongBio PharmaSeries C$29MWith 2 others
  33. May
    Acchrom TechSeries B$14MWith 1 other
  34. Feb
    Jiamai sharesVenture$14MWith 1 other
  35. Jan
    Bibost Automotive ElectronicsSeries B$41MWith 3 others
  36. 2024

    7 rounds

  37. Sept
    TachemSeries B$9.3MWith 3 others
  38. Sept
    Hope MedicineSeries B$19MWith 2 others
  39. Jul
    MoonBiotechSeries C$41MWith 2 others
  40. Apr
    MCT millimeter intelligenceSeed$14MSole investor
  41. Mar
    EdgeRockSeries A$14MSole investor
  42. Feb
    Shifan MicroelectronicsSeed$14MWith 1 other
  43. Feb
    Hydropeng TechnologySeed$1.4MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration1 named

NDNeelam DesaiMr. Desai is the Manager of General Partner.iFiling they signed

We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Highlight Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Highlight Capital put money into.

Quick answers about Highlight Capital

What does Highlight Capital invest in?

Highlight Capital invests most often at Series B and Venture (54% of the rounds on record), in sectors such as Healthcare and Technology.

How active is Highlight Capital?

78 investments on record, 11 of them in the last 12 months. The most recent was in May 2026.

What has Highlight Capital invested in recently?

Its most recent investments on record: Vivatides Therapeutics (Series A, May 2026), Nuclidium (Series B, May 2026) and ImageneBio (Undisclosed round, Apr 2026).

How big are Highlight Capital's cheques?

The median round it joins is $25M.

Does Highlight Capital lead rounds?

Rarely, if at all: none of its 78 investments on record names it as the lead.

Where does Highlight Capital invest?

Most of the companies it backs are in the United States (36%), Switzerland (27%) and China (9%).

Is Highlight Capital investing now?

Yes: it is actively investing, with 11 investments in the last 12 months.

Who does Highlight Capital invest alongside?

Most often Qiming Venture Partners (7 rounds together), CICC (5 rounds together) and Shunwei Capital (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it